Showing results (131-140 of 164) with videos related to

Sort By:
Pageof 17
Journal of Hepatology|May 14, 2013
SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinomaGuang-Zhi Jin, Wen-Long Yu, Hui Dong, et al.
International Journal of Cancer|August 29, 2019
Plasma circular RNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma: A large-scale, multicenter studyJian Yu, Wen-Bing Ding, Meng-Chao Wang, et al.
World Journal of Gastroenterology|August 27, 2005
Replication of hepatitis B virus in primary duck hepatocytes transfected with linear viral DNAYun-Qing Yao, Ding-Feng Zhang, Ni Tang, et al.
Hepatology (Baltimore, Md.)|June 19, 2012
Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomySheng-Xian Yuan, Fu Yang, Yuan Yang, et al.
Frontiers in Oncology|November 12, 2020
A High Preoperative Platelet-Lymphocyte Ratio Is a Negative Predictor of Survival After Liver Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: <i>A Retrospective Study</i>Yun Yang, Meng-Chao Wang, Tao Tian, et al.
World Journal of Gastroenterology|March 24, 2025
Preoperative prediction of textbook outcome in intrahepatic cholangiocarcinoma by interpretable machine learning: A multicenter cohort studyTing-Feng Huang, Cong Luo, Luo-Bin Guo, et al.
Hepatology (Baltimore, Md.)|May 13, 2015
Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1Sheng-xian Yuan, Jie Wang, Fu Yang, et al.
Gut|November 16, 2019
miR-541 potentiates the response of human hepatocellular carcinoma to sorafenib treatment by inhibiting autophagyWen-Ping Xu, Jin-Pei Liu, Ji-Feng Feng, et al.
Hepatology (Baltimore, Md.)|December 15, 2015
Systemic genome screening identifies the outcome associated focal loss of long noncoding RNA PRAL in hepatocellular carcinomaChuan-chuan Zhou, Fu Yang, Sheng-xian Yuan, et al.
British Journal of Cancer|December 16, 2022
Serum thrombospondin-1 serves as a novel biomarker and agonist of gemcitabine-based chemotherapy in intrahepatic cholangiocarcinomaDong-Yang Ding, Xiao-Jie Gan, Jia-Ning Zhang, et al.
Pageof 17